Cooper is a leading independent over-the-counter pharmaceutical business with operations in France, Netherlands and North Africa.
Cooper offers a large product selection to pharmacies in France with 500 product SKUs, covering a wide range of areas such as a cough & cold, vitality and pain relief.
Esas co-invested alongside the lead investor Charterhouse Capital in 2016.
https://www.cooper.fr/
Cooper offers a large product selection to pharmacies in France with 500 product SKUs, covering a wide range of areas such as a cough & cold, vitality and pain relief.
Esas co-invested alongside the lead investor Charterhouse Capital in 2016.
https://www.cooper.fr/
Location: France, Ile-of-France, Melun
Employees: 1-10
Investors 2
| Date | Name | Website |
| - | Esas Priva... | esaspe.com |
| 12.10.2020 | Charterhou... | charterhou... |
Mentions in press and media 2
| Date | Title | Description |
| 11.02.2022 | Mr. Cooper Group Inc. announces an Equity Buyback for $200 million worth of its shares. | Mr. Cooper Group Inc. (NasdaqCM:COOP) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its outstanding common stock. |
| 29.07.2021 | Mr. Cooper Group Inc. announces an Equity Buyback for $500 million worth of its shares. | Mr. Cooper Group Inc. (NasdaqCM:COOP) announces a share repurchase program. Under the program, the company will repurchase up to $500 million worth of its outstanding common stock. |